Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
05/1999
05/27/1999WO1999025857A2 Transgenic models of inflammatory disease
05/27/1999WO1999025843A2 Human checkpoint kinase, hcds1, compositions and methods
05/27/1999WO1999025830A1 Transcriptionally regulated g protein-coupled receptor
05/27/1999WO1999025734A2 Th2 CELL DEPLETION; COMPOSITIONS; METHODS
05/27/1999WO1999025383A1 Conjugates comprising two active agents
05/27/1999WO1999025382A1 Pharmaceutical combination of a cyclooxygenase-2 inhibitor
05/27/1999WO1999025374A1 Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
05/27/1999WO1999025372A1 Small peptides and methods for treatment of asthma and inflammation
05/27/1999WO1999025364A1 Method for treating attention deficit disorder
05/27/1999WO1999025363A1 Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
05/27/1999WO1999025361A1 Use of selected phytostenol esters for producing hypocholesteraemic preparations
05/27/1999WO1999025360A2 Progestogen-antiprogestogen regimens
05/27/1999WO1999025352A1 Combination therapy for the treatment of aids
05/27/1999WO1999025341A1 Use of histamine for elevating blood histamine levels
05/27/1999WO1999025340A1 Treatment for alzheimer's disease
05/27/1999WO1999025330A1 Treatment of scar tissue using lipoic acid
05/27/1999WO1999025324A1 Administering active substances by using the capsid produced out of the polyoma virus vp1 protein
05/27/1999WO1999018952B1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
05/27/1999WO1999012964A3 Kay - a novel immune system protein
05/27/1999WO1999012961A8 Estrogen receptor
05/27/1999WO1999012529A3 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
05/27/1999WO1999010480A3 New tissue-specific calpaines, their production and their use
05/27/1999DE19750354A1 Covering an inductor molecule with a viral capsid, for more efficient transfection of cells
05/27/1999CA2310255A1 Use of histamine for elevating blood histamine levels
05/27/1999CA2310250A1 Treatment for alzheimer's disease
05/27/1999CA2309966A1 Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
05/27/1999CA2309904A1 Transfection and transfer of male germ cells for generation of transgenic species
05/27/1999CA2309807A1 Transgenic models of inflammatory disease
05/27/1999CA2309761A1 Th2 cell depletion; compositions; methods
05/27/1999CA2309745A1 Progestogen-antiprogestogen regimens
05/27/1999CA2309392A1 Method for treating attention deficit disorder
05/27/1999CA2309339A1 Transcriptionally regulated g protein-coupled receptor
05/27/1999CA2309325A1 Hypocholesteraemic preparations containing phytostenolesters of conjugated fatty acids, and methods of reducing serum cholesterol levels using the same
05/27/1999CA2309164A1 Combination therapy for the treatment of aids
05/27/1999CA2306492A1 Human checkpoint kinase, hcds1, compositions and methods
05/26/1999EP0917874A1 Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
05/26/1999EP0917873A1 Eyedrops
05/26/1999EP0917577A2 Herpes simplex virus icp4 is an inhibitor of apoptosis
05/26/1999EP0917539A1 Anticoagulant peptide fragments derived from apolipoprotein b-100
05/26/1999EP0917535A1 Neuroactive peptide
05/26/1999EP0917471A2 Treatment and diagnosis of infections of gram positive cocci
05/26/1999EP0917462A1 Cell adhesion inhibitors
05/26/1999EP0917461A1 Device for topical treatment of acne and its method of manufacture
05/26/1999EP0917427A1 Teat dipping agent
05/26/1999EP0869789A4 Antiviral agent
05/26/1999EP0516795B1 Medicaments containing a quisqualate receptor antagonist and a dopamine agonist for the treatment of parkinson's disease
05/26/1999CN1217213A Medicine for treating liver cancer and stomach cancer
05/25/1999US5906977 Conjugate for treating inflammatory diseases
05/25/1999US5906832 Time release agents for epileptic drugs into intestines
05/20/1999WO1999024603A1 Method for identifying drug targets
05/20/1999WO1999024601A1 Secreted protein nsl4
05/20/1999WO1999024583A1 Dna demethylase, therapeutic and diagnostic uses thereof
05/20/1999WO1999024582A1 Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
05/20/1999WO1999024579A1 Novel era
05/20/1999WO1999024471A1 Opiate, cannabinoid, and estrogen receptors
05/20/1999WO1999024401A1 Use of alkylated iminosugars to treat multidrug resistance
05/20/1999WO1999024159A1 Encapsulate of active material in alginate matrix
05/20/1999WO1999024077A2 Compositions and methods for targeted delivery of biologically-active factors
05/20/1999WO1999024072A1 Release-sustaining agent for drugs and sustained-release pharmaceutical composition
05/20/1999WO1999024051A2 Application of vasopressin antagonists for treating disturbances or illnesses of the inner ear
05/20/1999WO1999024046A1 Synergetic oral composition combining sulphuric chondroitin acid and/or dna with hydroxyproline
05/20/1999WO1999024045A1 Methods for treatment of tumors and tumor cells using ex vivo activated t cells
05/20/1999WO1999024024A2 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists
05/20/1999WO1999024009A1 Uses of d-xylose, the esters thereof and oligosaccharides containing xylose for improving the functionality of epidermal cells
05/20/1999WO1999018213A8 MUTANTS OF YEAST Cdc24p, DEFECTIVE IN BINDING OF THE G-PROTEIN BETA SUBUNIT
05/20/1999WO1999015653A3 Tie ligand homologues
05/20/1999WO1999015553A3 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use
05/20/1999WO1999015162A3 Treatment and prevention of immunodeficiency virus infection by administration of non-pyrogenic derivatives of lipid a
05/20/1999WO1999009967A3 Cholesterol-lowering therapy
05/20/1999WO1999009182A3 Rab proteins
05/20/1999WO1999008718A3 Bioresorbable compositions for implantable prostheses
05/20/1999WO1999007736A3 Lipoprotein-regulating medicaments
05/20/1999WO1999007734A3 Hepatitis c inhibitor peptide analogues
05/20/1999WO1999001118A9 Antioxidant enhancement of therapy for hyperproliferative conditions
05/20/1999WO1998048785A9 Allelic polygene diagnosis of reward deficiency syndrome and treatment
05/20/1999CA2310213A1 Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
05/20/1999CA2309597A1 Sustainedly releasing agents for medicines and sustainedly released medicinal compositions containing the same
05/20/1999CA2309321A1 Use of alkylated iminosugars to treat multidrug resistance
05/20/1999CA2309206A1 Methods for treatment of tumors and tumor cells using ex vivo activated t cells
05/20/1999CA2309117A1 Application of vasopressin antagonists for treating disturbances or illnesses of the inner ear
05/20/1999CA2308582A1 Method for identifying drug targets
05/19/1999EP0916729A2 Novel reductase
05/19/1999EP0916727A2 Novel LysS
05/19/1999EP0916346A2 NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
05/19/1999EP0916337A2 Use of inhibitors of the sodium-hydrogen exchange in the manufacture of amedicament for reducing unwanted effects of compounds on the heart.
05/19/1999EP0915974A1 Modified tie-2-receptor ligands
05/19/1999EP0915969A1 Method for preventing hiv-1 infection of cd4+ cells
05/19/1999EP0915709A1 The use of proteinase inhibitors for prevention or reduction of bone resorption
05/19/1999EP0915706A1 Screening methods for compounds useful in the regulation of body weight
05/19/1999EP0915703A1 Combinations of an ursodeoxycholic acid compound and a nsaid for the chemopreventive protection of the colorectum
05/19/1999EP0915698A1 Therapeutic treatment for vegf related diseases
05/19/1999EP0756477A4 Methods for phototherapeutic treatment of proliferative skin diseases
05/19/1999EP0633887B1 Calanolide antiviral compounds, compositions and uses thereof
05/19/1999CN1216995A Amphipathic molecules as cholesterol and other lipid uptake inhibitors
05/19/1999CN1216994A Apoptosis inducing molecule II
05/18/1999US5905083 Method of treating rheumatoid arthritis
05/18/1999US5905070 5--Caboxamido or 5--fluoro!-- 2', 3'--unsaturated or 3'--modified!--pyrimidine nucleosides
05/18/1999US5904938 Anticoagulants using nitric oxide by breathing
05/18/1999US5904932 Topical preparation containing a suspension of solid lipid particles
05/18/1999US5904144 Method for delivering a biologically active molecule to the eye
1 ... 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 ... 1151